ArticleViruses2025
Seroprevalence and Risk Factors of Crimean-Congo Hemorrhagic Fever Exposure in Wild and Domestic Animals in Benin.
Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Zoonotic arboviruses and associated risk factors in donkeys from northeastern Algeria.Tropical animal health and production · 2026Article
- Crimean-Congo Haemorrhagic Fever Virus Exposure in Horses and Donkeys in Border Livestock Markets of Nigeria.Zoonoses and public health · 2026Article
- Widespread circulation of Crimean-Congo haemorrhagic fever virus in ticks, Corsica (France), 2024.One health (Amsterdam, Netherlands) · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne zoonotic viral disease prevalent in Africa. While infection is asymptomatic in animals, it can cause severe illness with hemorrhagic manifestations and high mortality rates in humans. This study aimed to determine the seroprevalence and potential risk factors of CCHF in wild (rodents, birds) and domestic (cattle, horses) animals in Benin. A cross-sectional study was carried out from 2022 to 2024 with the assistance of cattle breeders, hunters, farmers and bushmeat sellers in 15 districts found in three agroecological zones in the country. A total of 366 serum samples were analyzed, comprising 254 collected from wild animals and 112 from domestic animals. Among the wild animals tested, 1.18% (95% CI: 0.31-3.70; n = 3) were seropositive for antibodies against CCHF virus (CCHFV). The seroprevalence rates were 3.7% (95% CI: 0.19-20.89) in squirrels, 5.88% (95% CI: 0.31-30.76) in hares and 1.19% (95% CI: 0.06-7.38) in giant rats. In domestic animals, anti-CCHFV antibodies were detected in 38 of the 112 samples, resulting in an overall seroprevalence of 33.93% (95% CI: 25.42-43.56). Specifically, antibodies were identified in 34 out of 81 cattle (41.98%, 95% CI: 31.26-53.46) and 4 out of 24 horses (16.67%, 95% CI: 5.48-38.19). No positive samples were reported in pigeons. This study provides the first seroprevalence data on CCHF in wild and domestic animals in Benin. It highlights the risk and epidemiological dynamics of the disease and underscores the need for further investigations into tick vectors and human populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.